A novel function of junctional adhesion molecule-C in mediating melanoma cell metastasis

Cancer Research

Volumn 71, Issue 12, 2011, Pages 4096-4105

  Langer, Harald F ^a,b   Orlova, Valeria V ^a,c   Xie, Changping ^d   Kaul, Sunil ^a   Schneider, Darius ^d   Lonsdorf, Anke S ^a,d   Fahrleitner, Manuela ^b   Choi, Eun Young ^a,j   Dutoit, Vanessa ^d   Pellegrini, Manuela ^f   Grossklaus, Sylvia ^g   Nawroth, Peter P ^d   Baretton, Gustavo ^g   Santoso, Sentot ^h   Hwang, Sam T ^a,i   Arnold, Bernd ^e   Chavakis, Triantafyllos ^a,d,g  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^h Institute for Clinical Immunology and Transfusion Medicine   (Germany)

ⁱ MEDICAL COLLEGE OF WISCONSIN   (United States)

^j University of Ulsan   (South Korea)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE PROTEIN; JUNCTIONAL ADHESION MOLECULE C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELETION; IN VIVO STUDY; LUNG METASTASIS; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; SULFATION;

ANIMALS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL MOVEMENT; CHO CELLS; CRICETINAE; CRICETULUS; ENDOTHELIAL CELLS; HUMANS; IMMUNOGLOBULINS; LUNG NEOPLASMS; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS;

EID: 79958863561     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-2794     Document Type: Article

References (39)

1. Chambers AF, Naumov GN, Varghese HJ, Nadkarni KV, MacDonald IC, Groom AC. Critical steps in hematogenous metastasis: an overview. Surg Oncol Clin N Am 2001;10:243-55.
2. Cohn-Cedermark G, Mansson-Brahme E, Rutqvist LE, Larsson O, Singnomklao T, Ringborg U. Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma. Acta Oncol 1999;38:549-57. (Pubitemid 29333734)
3. Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM. Interactions between cancer cells and the endothelium in metastasis. J Pathol 2000;190:310-29. (Pubitemid 30141377)
4. Cardones AR, Murakami T, Hwang ST. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin. Cancer Res 2003;63:6751-7.
5. Liang S, Dong C. Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions. Am J Physiol Cell Physiol 2008;295:C701-7.
6. Murakami T, Maki W, Cardones AR, Fang H, Tun Kyi A, Nestle FO, et al. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 2002;62:7328-34. (Pubitemid 36025256)
7. Okahara H, Yagita H, Miyake K, Okumura K. Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. Cancer Res 1994;54:3233-6.
8. Saalbach A, Wetzel A, Haustein UF, Sticherling M, Simon JC, Anderegg U. Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium. Oncogene 2005;24:4710-20. (Pubitemid 41032607)
9. Melnikova VO, Bar-Eli M. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res 2006;19:395-405. (Pubitemid 44326401)
10. Bradfield PF, Nourshargh S, Aurrand-Lions M, Imhof BA. JAM family and related proteins in leukocyte migration (Vestweber series). Arterioscler Thromb Vasc Biol 2007;27:2104-12. (Pubitemid 350287237)
11. Orlova VV, Chavakis T. Regulation of vascular endothelial permeability by junctional adhesion molecules (JAM). Thromb Haemost 2007;98:327-32. (Pubitemid 47250235)
12. Weber C, Fraemohs L, Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 2007;7:467-77. (Pubitemid 46834851)
13. Immenschuh S, Naidu S, Chavakis T, Beschmann H, Ludwig RJ, Santoso S. Transcriptional induction of junctional adhesion molecule-C gene expression in activated T cells. J Leukoc Biol 2009;85:796-803.
14. Orlova VV, Economopoulou M, Lupu F, Santoso S, Chavakis T. Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J Exp Med 2006;203:2703-14. (Pubitemid 44833346)
15. Santoso S, Sachs UJ, Kroll H, Linder M, Ruf A, Preissner KT, et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med 2002;196:679-91. (Pubitemid 35024445)
16. Aurrand-Lions M, Lamagna C, Dangerfield JP, Wang S, Herrera P, Nourshargh S, et al. Junctional adhesion molecule-C regulates the early influx of leukocytes into tissues during inflammation. J Immunol 2005;174:6406-15. (Pubitemid 40663834)
17. Keiper T, Al-Fakhri N, Chavakis E, Athanasopoulos AN, Isermann B, Herzog S, et al. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J 2005;19:2078-80. (Pubitemid 41759771)
18. Lamagna C, Meda P, Mandicourt G, Brown J, Gilbert RJ, Jones EY, et al. Dual interaction of JAM-C with JAM-B and alpha(M)beta2 integrin: function in junctional complexes and leukocyte adhesion. Mol Biol Cell 2005;16:4992-5003.
19. Johnson-Leger CA, Aurrand-Lions M, Beltraminelli N, Fasel N, Imhof BA. Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration. Blood 2002;100:2479-86.
20. Santoso S, Orlova VV, Song K, Sachs UJ, Andrei-Selmer CL, Chavakis T. The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions. J Biol Chem 2005;280:36326-33. (Pubitemid 41633906)
21. Li X, Stankovic M, Lee BP, Aurrand-Lions M, Hahn CN, Lu Y, et al. JAM-C induces endothelial cell permeability through its association and regulation of {beta}3 integrins. Arterioscler Thromb Vasc Biol 2009;29:1200-6.
22. Fuse C, Ishida Y, Hikita T, Asai T, Oku N. Junctional adhesion molecule-C promotes metastatic potential of HT1080 human fibrosarcoma. J Biol Chem 2007;282:8276-83. (Pubitemid 47093624)
23. Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, et al. Adherent platelets recruit and induce differentiation of murine embryonic endothelial progenitor cells to mature endothelial cells in vitro. Circ Res 2006;98:e2-10.
24. Choi EY, Chavakis E, Czabanka MA, Langer HF, Fraemohs L, Economopoulou M, et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science 2008;322:1101-4.
25. Economopoulou M, Langer HF, Celeste A, Orlova VV, Choi EY, Ma M, et al. Histone H2AX is integral to hypoxia-driven neovascularization. Nat Med 2009;15:553-8.
26. Langer HF, Chung KJ, Orlova VV, Choi EY, Kaul S, Kruhlak MJ, et al. Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood 2010;116:4395-403.
27. Chavakis T, Keiper T, Matz-Westphal R, Hersemeyer K, Sachs UJ, Nawroth PP, et al. The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo. J Biol Chem 2004;279:55602-8. (Pubitemid 40066564)
28. Murakami T, Cardones AR, Finkelstein SE, Restifo NP, Klaunberg BA, Nestle FO, et al. Immune evasion by murine melanoma mediated through CC chemokine receptor-10. J Exp Med 2003;198:1337-47. (Pubitemid 37392479)
29. Mandicourt G, Iden S, Ebnet K, Aurrand-Lions M, Imhof BA. JAM-C regulates tight junctions and integrin-mediated cell adhesion and migration. J Biol Chem 2007;282:1830-7. (Pubitemid 47076730)
30. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
31. Praetor A, McBride JM, Chiu H, Rangell L, Cabote L, Lee WP, et al. Genetic deletion of JAM-C reveals a role in myeloid progenitor generation. Blood 2009;113:1919-28.
32. Gliki G, Ebnet K, Aurrand-Lions M, Imhof BA, Adams RH. Spermatid differentiation requires the assembly of a cell polarity complex downstream of junctional adhesion molecule-C. Nature 2004;431:320-4. (Pubitemid 39265668)
33. Pellegrini M, Claps G, Orlova VV, Barrios F, Dolci S, Geremia R, et al. , Targeted JAM-C deletion in germ cells by Spo11-controlled Cre recombinase. J Cell Sci 2011;124:91-9.
34. Gothert JR, Gustin SE, van Eekelen JA, Schmidt U, Hall MA, Jane SM, et al. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endothelium. Blood 2004;104:1769-77. (Pubitemid 39202286)
35. Alva JA, Zovein AC, Monvoisin A, Murphy T, Salazar A, Harvey NL, et al. VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells. Dev Dyn 2006;235:759-67.
36. Abbott DE, Bailey CM, Postovit LM, Seftor EA, Margaryan N, Seftor RE, et al. The epigenetic influence of tumor and embryonic microenvironments: how different they are? Cancer Microenviron 2008;1:13-21.
37. Wegmann F, Petri B, Khandoga AG, Moser C, Khandoga A, Volkery S, et al. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med 2006;203:1671-7. (Pubitemid 44036272)
38. Cangara HM, Ishida T, Hara T, Sun L, Toh R, Rikitake Y, et al. Role of endothelial cell-selective adhesion molecule in hematogeneous metastasis. Microvasc Res 2010;80:133-41.
39. Tenan M, Aurrand-Lions M, Widmer V, Alimenti A, Burkhardt K, Lazeyras F, et al. Cooperative expression of junctional adhesion molecule-C and -B supports growth and invasion of glioma. Glia 2010;58:524-37.